YS Biopharma (NASDAQ:YS) Trading 7.6% Higher

YS Biopharma Co., Ltd. (NASDAQ:YS) traded up 7.6% during trading on Friday . The company traded as high as $0.85 and last traded at $0.84. 398,477 shares traded hands during trading, an increase of 131% from the average session volume of 172,401 shares. The stock had previously closed at $0.78.

YS Biopharma Trading Up 7.6 %

The company has a current ratio of 0.94, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a 50-day moving average price of $0.52 and a 200 day moving average price of $0.67.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in YS Biopharma stock. Ovata Capital Management Ltd acquired a new position in shares of YS Biopharma Co., Ltd. (NASDAQ:YS) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 150,000 shares of the company’s stock, valued at approximately $153,000. Ovata Capital Management Ltd owned approximately 0.16% of YS Biopharma as of its most recent filing with the Securities & Exchange Commission. 52.64% of the stock is currently owned by institutional investors and hedge funds.

About YS Biopharma

YS Biopharma Co, Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.